HOME >> MEDICINE >> NEWS
Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson's to pain

ks activity in the cannabinoid system can significantly reduce food intake in animals by triggering activity in another system that is known to regulate appetite and body weight," says study author Michael Cowley, PhD, of Oregon Health and Science University.

Obesity has risen at an epidemic rate during the past 20 years, according to the Centers for Disease Control and Prevention. More than 60 percent of adult Americans are overweight or obese. These people face an increased risk for a range of physical ailments, including high blood pressure, diabetes, and stroke.

"For many years anecdotal reports have described how marijuana use can increase appetite," says Cowley. "Some users describe these cravings as the munchies."

This and other work has prompted the development of drugs that combat appetite by blocking the cannabinoid receptors, which are activated by marijuana. "Some of these drugs are in late stage clinical trials," says Cowley. "How they are able to control eating, however, has been a mystery."

To shed some light on how they might work, Cowley and his colleagues gave mice a cannabinoid receptor blocker, termed AM251. "We found that the treated animals significantly reduced their food intake, as has been known for many years," says Cowley. "We also found evidence that the activity of brain cells involved in the melanocortin system, which is known to control food intake and energy balance, increased."

Several molecular measures signaled that there was increased activity in melanocortin brain cells. Included was the discovery that in treated animals there was a fourfold increase in the number of melanocortin brain cells that contained c-fos, a marker of cellular activation.

"These data show that cannabinoid receptor blockers can regulate the melanocortin pathways in animals and support the further development of cannabinoid blockers to help combat obesity in humans," says Cowley.


'"/>

Contact: Leah Ariniello
dawn@sfn.org
202-462-6688
Society for Neuroscience
26-Oct-2004


Page: 1 2 3 4 5

Related medicine news :

1. New compounds effective against Alzheimers disease onset and progression
2. New compounds show promise in fighting malaria and cancer
3. New class of compounds promises to revive failing hearts
4. Study finds certain compounds in beer, wine effective in slowing breast cancer cell growth
5. Researchers testing compounds that may stop replication of T-cell leukemia virus
6. Cocoa froths with cancer-preventing compounds
7. OneWorld Health licenses compounds from Yale, U of Washington to treat major parasitic diseases
8. Purdue stealth compounds attack cancer cells
9. Englewood researcher receives national award: Fights cancer with vaccines and compounds found in nature
10. Flu vaccination benefits people of any age with high-risk medical conditions
11. Most alcohol-related plane crashes occur at night and in worsening weather conditions

Post Your Comments:
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Greater participation in music ... finds. Researchers followed kids in the nonprofit Harmony ... children in Los Angeles. Over two years, children ... in how the brain processes speech and reading, compared ... the benefits of active participation in music classes occurred ...
(Date:12/15/2014)... OR (PRWEB) December 15, 2014 A ... by United States women as impacting skin health and ... “Four C’s of skin care.” Water and health advocate ... in a recent article describing the survey and the ... every item in every category discussed would benefit from ...
(Date:12/15/2014)... 2014 South Florida’s leading urgent care provider, ... be a daze of hassle, hustle, and bustle that can ... halls, to burns when making special meals and heartburn after ... happen at any time. To prevent this season of joy ... a list of helpful and healthful holiday tips to keep ...
(Date:12/15/2014)... HealthDay Reporter FRIDAY, Dec. 12, 2014 (HealthDay ... of American women who have migraine: The debilitating headaches don,t ... association between migraine and breast cancer risk," said lead researcher ... School. "There is no positive association, so there is no ... About 18 percent of American women and 6 percent ...
(Date:12/15/2014)... December 15, 2014 Emergo Group, Inc., ... 26 countries in North and South America, Europe, the ... from industry participants for its 2015 Medical Device Industry ... to identify upcoming business and market trends as well ... The survey targets areas including:, , ...
Breaking Medicine News(10 mins):Health News:Music Classes Boost Language Skills, Study Says 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "MEMS Gyroscopes Analog Devices ADIS16136 Precision ... to their offering. ... grade applications made a lot of progress in ... They are now accepted in high-reliability environments, and ...
(Date:12/15/2014)... , December 15, 2014 BerGenBio ... for aggressive drug resistant cancers, today announces that it ... private placing from new and existing investors. ... support the development of its pipeline of innovative cancer ... its lead drug candidate, BGB324, a first-in-class selective Axl ...
Breaking Medicine Technology:RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2BerGenBio Completes NOK90 Million Fundraising 2
Cached News: